Alcon misses Q1 earnings, trims outlook; shares fall over 8%

Published 14/05/2025, 10:42

Investing.com -- Alcon (NYSE:ALC) AG (SIX:ALCC) missed first-quarter earnings expectations and cut its full-year guidance, sending shares down more than 8% on Wednesday amid broad softness in its Surgical and Vision Care segments.

The company reported net sales of $2.45 billion for the quarter, up 0.3% year-over-year, or 2.6% in constant currency. The result missed both BTIG’s estimate and the Street’s estimate of $2.51 billion.

Surgical revenue totaled $1.33 billion, down 0.5% from a year ago, or up 2.5% excluding currency. 

That fell short of BTIG’s estimate of $1.38 billion and consensus at $1.37 billion. Consumables rose 3.8%, offset by declines in Implantables and Equipment. 

Implantables fell 3% and were flat in constant currency, while Equipment and Other dropped 9.1%, due to lower demand for legacy cataract and vitreoretinal systems. 

Alcon said its Unity platform is not expected to contribute meaningfully until the second half of the year.

Vision Care sales rose 1.3% to $1.12 billion, or 3.3% in constant currency, below BTIG and consensus expectations. 

Contact Lenses grew 2.5%, led by innovations in multifocals and torics. Ocular Health declined 0.7%, with growth driven by Systane and price increases. 

Alcon noted a 3% benefit in the prior year from China eye drop sales that have since been divested.

Core earnings per share were $0.73, below BTIG’s estimate of $0.79 and consensus of $0.75. The company cited a $0.03 per-share impact from dilution related to its acquisition of Aurion Biotech.

Alcon cut its 2025 core EPS forecast to $3.05–$3.15, from $3.15–$3.25, including about $0.10 of pressure from recent business development. 

It also lowered its core operating margin guidance to 20%–21% from 21%–22%. First-quarter core operating margin was 20.8%, above the Street’s 20.5% estimate.

Sales guidance was revised to $10.4 billion–$10.5 billion, slightly higher than the prior $10.2 billion–$10.4 billion range due to favorable currency. 

Growth is now expected at 6%–7% constant currency, down from 6%–8%. A $80 million tariff headwind is expected to be fully offset by operational actions and foreign exchange.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.